Macrophages are involved in defense against bacterial colonization and infection (7, 20) . In addition to their role in bacterial phagocytosis, they play an important part in amplification of the host immune response. Through release of potent immunomodulators, inflammation and wound healing occur at an accelerated rate (25) . Furthermore, antigen processing and presentation by macrophages is involved in T-cell recognition of antigens in the cellular and humoral immune responses.
In previous studies (11, 14) it was determined that Pseudomonas aeruginosa cells taken directly from an in vivo peritoneal chamber growth system were significantly more susceptible to phagocytosis by macrophages than were the same cells after being washed in buffer. The phagocytosispromoting factor was isolated from the supernatant of centrifuged in vivo-grown bacteria and was determined to be fibronectin (14) . This molecule was capable of increasing nonopsonic uptake of P. aeruginosa grown in vivo in rats or mice or in vitro on agar plates. It was subsequently demonstrated that promotion by fibronectin of nonopsonic phagocytosis was mediated by the direct action of fibronectin on the macrophages (13) . The tetrapeptide arginine-glycineaspartate-serine (RGDS), from the eucaryotic cell-binding domain of fibronectin, was also capable of stimulating macrophages for enhanced phagocytosis of P. aeruginosa (13) .
As fibronectin-stimulated phagocytosis of P. aeruginosa occurred in the absence of opsonins, the resulting uptake must be considered nonopsonic. Speert and colleagues have presented evidence that nonopsonic phagocytosis of P. aeruginosa by human neutrophils and monocyte-derived macropiiages was higher in three piliated, hydrophobic P. aeruginosa isolates than in two nonpiliated, hydrophilic isolates (26) . However, these strains were not isogenic, and further investigation revealed a weakly piliated isolate that was not susceptible to nonopsonic phagocytosis (16 facturer. Antibiotic concentrations were 50 jxg/ml for ampicillin and chloramphenicol, 150 ,ug/ml for tetracycline, and 300 pug/ml for carbenicillin. The mercuric chloride concentration was 15 pug/ml.
Bacterial growth in vivo. Chambers for implantation into rats were constructed from 3-ml polypropylene syringe barrels as previously described (12) . Briefly, washed bacteria were inoculated into plastic chambers which were sealed on either end with 0.22-,um-pore-size filters. When these chambers were inserted into the peritoneal cavity of laboratory animals, the filters allowed free exchange of peritoneal fluids and small bacterial products while prohibiting bacterial escape or direct immune cell access to the organisms. Bacterial (Hausser Scientific, Blue Bell, Pa.) and maintained on ice until use. Washed organisms were centrifuged at 1,200 x g and gently resuspended in PBS twice prior to assay. The first decanted supernatant from these cells was saved for assessment of phagocytosis enhancement (in vivo supernatant).
Maintenance of macrophage cell line. Mouse macrophage cell line P388D1 was maintained at 37°C in 10% CO2 in Nunc flat-bottomed flasks (Gibco, Burlington, Ontario) with supplemented RPMI-1640 medium (Gibco) as described previously (14) . Prior to assay, macrophages were grown for 16 h in Nunclon petri dishes (Gibco; 35 by 10 mm) at a concentration of 106 cells per dish. Nonadherent cells were removed by gently washing the monolayer with unsupplemented RPMI-1640 (phagocytosis buffer).
Phagocytosis assay. The visual assay for phagocytosis was performed as described previously (2) . Briefly, 1 ml of phagocytosis buffer was added to a washed macrophage monolayer to give a final concentration of 106 cells per ml.
To assess enhancement of phagocytosis, PBS, in vivo supernatant (100 ,ul), 50 ,ug of bovine plasma fibronectin (Sigma Chemical Co., St. Louis, Mo.) or 50 ,ug of the tetrapeptide RGDS (Sigma) was added to the assay volume. No additional opsonins or macrophage activators were included in the system. The bovine fibronectin was demonstrated by the Limulus amoebocyte lysate assay to contain less than 0.1 ng of endotoxin per 50 ,ug of fibronectin. Bacterial cells were used at a P. aeruginosa-macrophage ratio of 20:1, and phagocytosis was allowed to occur for 90 min at 37°C in a 10% CO2 atmosphere. Uptake was assessed visually following Diff-quik staining (Canlab, Vancouver, Canada). When used, 60 ,ug of purified PAO1 pili per ml, prepared as described previously (17) , was incubated with in vivo supernatant-, fibronectin-, or RGDS-activated macrophages for 15 min at 37°C in 10% CO2 prior to the addition of bacteria. This concentration of pili was chosen on the basis of analogous experiments with human neutrophils (18) .
Characterization of bacterial cell envelopes and lipopolysaccharide samples. Bacterial cell envelopes were isolated from P. aeruginosa H103 as described previously (12) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed as described previously (10, 12 (15, 18) . Triparental matings were performed as described by Pasloske and Paranchych (19) . The conjugation of pMR5 into P. aeruginosa was performed as described earlier (21) .
Construction of pilin-minus, isogenic P. aeruginosa PAO1. A cosmid bank was obtained from P. aeruginosa PAK DNA by using the vector pLAFR1 (8) A triparental mating was performed with MM294 (pRK2013) as the donor of the mobilizing plasmid to mobilize pBP311 into P. aeruginosa PAO1-leu, and the transconjugant was selected on PIA containing tetracycline (to select plasmid sequences) and Hg (to select the inserted TnSOI). The cells were passaged every 12 h for 120 h with shaking at 37°C in LB broth and without antibiotic selection to allow gene replacement to occur through a double homologous recombination. A successful gene replacement would result in P. aeruginosa becoming resistant to the pilus-specific bacteriophage P04. Therefore, to select for pilA::TnSOI mutants, the passaged cells were incubated with a 10,000-fold excess of P04 for 30 min at 37°C and then grown at 30°C on LB agar containing Hg. Approximately 0.5% of these cells were phage-resistant, but they were also Tcr, indicating that these mutants had retained pBP311.
To cure the phage-resistant mutant of pBP311, the temperature-sensitive plasmid pMR5 (21) was conjugated into the resistant strain, and transconjugants were selected on PIA containing carbenicillin. Plasmids pMR5 and pBP311 belong to the same incompatibility group, IncP, and therefore cannot coexist in P. aeruginosa. Having expelled pBP311 with pMR5 from the phage-resistant strain, the bacteria were cured of pMR5 by growing the cells at 44°C for 18 h, since the plasmid is unstable at this temperature. Loss of pMR5 was determined by the mutant regaining its CbS and Tcs phenotypes. One isolate (P. aeruginosa BLP3) which had been cured of pMR5 also retained its resistance to Hg and P04 phage. Equivalent digests of genomic DNA from the mutant BLP3 and the wild-type strain PAO1 which were probed with a DNA pilin probe were found to have different restriction patterns (Fig. 1) . The mutant had the restriction pattern expected from a Tn501 insertion into the pilin gene. Electron microscopy showed that these cells were bald of pili. Mobilizing pBP161 (carrying the PAO pilin gene) into the mutant also restored P04 sensitivity, and pili were assembled by these transconjugants, as observed by electron microscopy.
Construction of broad-host-range plasmid expressing the PAO pilin gene. The PAO pilin gene clone pBP101 (19) was digested with HindlIl and Sall, and the 1,134-base-pair fragment carrying the PAO pilin gene was isolated by electrophoresis on 5% acrylamide (15) . This fragment was cloned into the HindIII and Sall restriction sites of pUC19 to yield plasmid pBP160. Both plasmids pBP160 and pKT210 were digested with EcoRI, ligated together, and transformed into Escherichia coli JM83, and transformants were selected on LB agar containing ampicillin and chloramphenicol. One of these clones (pBP161) was mobilized into P. aeruginosa BLP3 by a triparental mating, and transconjugants were selected on PIA containing carbenicillin.
RESULTS
In a previous investigation, it was determined that treating macrophages with fibronectin resulted in enhanced uptake of P. aeruginosa strains grown on agar plates but not of bacteria grown in agitated broth (14) . These grown in the three growth conditions failed to indicate any detectable alterations in rapidly agitated cultures compared with statically or plate-grown cultures (data not shown). Determination of the bacterial ligand for nonopsonic phagocytosis. In previous studies, it was suggested that Pseudomonas adherence to human epithelial cells (6, 29) and neutrophils and leukocytes (16, 26) was pilus mediated. Therefore, we considered the possibility that pili were the bacterial ligands involved in fibronectin-mediated macrophage stimulation. Electron microscopic observation of cells grown under the above conditions revealed that cells grown with rapid agitation were devoid of surface pili, whereas those grown in static broth contained 1 or more pili per bacterium, as previously observed for another P. aeruginosa strain (26) .
This suggested surface pili as the potential bacterial ligand responsible for enhanced interaction of statically grown P. aeruginosa strains with fibronectin-stimulated macrophages. Therefore, a pilus-free mutant of P. aeruginosa PAO1-leu was created by cosmid cloning of the P. aeruginosa PAK pilin gene into E. coli (18) , TnS01 mutagenesis of the cloned pilA gene, mobilization of the transposon-mutagenized gene (pilA::Tn501) into P. aeruginosa PAO1-leu by triparental mating, phage selection for homologous recombination into the chromosome, and plasmid curing (see Materials and Methods). The resultant mutant, BLP3, was mercury resistant and contained the pilA::Tn5rO mutation in its chromosome, as revealed by Southern hybridization of a pilA gene probe with restriction digests of strain BLP3 genomic DNA. As a control, the pilin phenotype was reconstituted by mobilizing plasmid pBP161, containing the cloned P. aeruginosa PAO pilA gene, back into strain BLP3, to create strain BLP3(pBP161). Electron microscopic examination revealed that strain BLP3 was devoid of surface pili, and susceptibility testing revealed that it was resistant to the PA01 pilusspecific phage P04. Both the parent strain PAO1-leu and BLP3(pBP161) were piliated and phage P04 sensitive. When grown on Trypticase soy agar plates, strains PAO1-leu and BLP3(pBP161) were significantly better taken up by macrophages stimulated with rat or bovine fibronectin or by the conserved fibronectin cell-binding tetrapeptide RGDS than they were by unstimulated macrophages (Table 3 ). In contrast, there was no significant difference in the extent of phagocytosis of the nonpiliated mutant BLP3 by stimulated or unstimulated macrophages. Similar data were obtained when these strains were grown in peritoneal chambers in mice.
To confirm pili as the bacterial ligand for nonopsonic phagocytosis, purified pili (60 jig/ml) were pili prevented enhanced uptake of strain H103 by macrophages activated by any of the three preparations (Table 4) . DISCUSSION The data presented in this paper demonstrate that the P. aeruginosa pilus was the bacterial ligand responsible for the observed enhanced nonopsonic phagocytosis by fibronectinactivated macrophages. Fibronectin promotion of macrophage phagocytosis was observed with P. aeruginosa grown on agar plates and in static broth, but not with rapidly agitated cultures (Table 1) . These data correlated well with the absence of pili on bacteria grown with shaking. Furthermore, fibronectin was unable to enhance uptake of a constructed mutant strain of P. aeruginosa lacking surface pili (Table 2 ). In addition, exogenously added pili suppressed phagocytosis of P. aeruginosa PAO1 by fibronectin or RGDS-stimulated macrophages to the level observed with untreated macrophages.
The data presented in this paper are consistent with previous studies showing that heavily piliated strains of P. aeruginosa are generally more susceptible to nonopsonic phagocytosis by neutrophils than less-piliated strains (15, 25) . It was also determined that exogenous pili were capable of inhibiting nonopsonic uptake of this organism by neutrophils (16) . These studies utilized freshly isolated human peripheral blood neutrophils. Although these authors did not investigate the role of fibronectin, given the high concentrations of fibronectin in human serum (0.7 ,uM) and our own inability to reverse fibronectin effects by washing fibronectin-treated macrophages (13), we would predict that the phagocytes they used were already fibronectin stimulated. P. aeruginosa pili have also been shown to mediate binding to epithelial (6, 29) and epidermal (24) cells. We propose that the role of pili in nonopsonic phagocytosis is to mediate initial bacterial attachment to macrophages and neutrophils. While the mucoid alginate exopolysaccharide can also mediate binding to epithelial cells (5) , it must be noted that the strains studied here were nonmucoid and that phage-selected mucoid derivatives of P. aeruginosa PAO1 were still susceptible to fibronectin-promoted nonopsonic phagocytosis (J. Kluftinger and R. E. W. Hancock, unpublished observations).
It has been suggested previously that fibronectin promotes phagocytosis of particles coated with C3b or C3bi via the macrophage receptors CR1 and CR3, respectively (30) . This response occurs rapidly and is not accompanied by a change in the number of receptor molecules on the surface of the phagocyte (30) . Recent data have suggested that the macrophage receptor for nonopsonic phagocytosis of P. aeruginosa is the mannose receptor (30) . Interestingly, nonopsonic phagocytosis of E. coli also occurs via the mannose receptor and appears to be mediated by mannose-sensitive pili (3). Thus, it is of interest to determine exactly how fibronectin influences the mannose receptor to promote a functional interaction with P. aeruginosa pili.
